Avanir Pharmaceuticals' P2P Acquisition

Avanir Pharmaceuticals raised a round of funding on December 02, 2014. Investors include Otsuka Holdings.

AVANIR Pharmaceuticals is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. The Company develops treatm…

Articles about Avanir Pharmaceuticals' P2P Acquisition: